SSRRX
Price
$7.64
Change
+$0.03 (+0.39%)
Updated
Jul 31 closing price
Net Assets
1.76B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

SSRRX vs VSCIX

SSRRX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
SSRRX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SSRRX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. SSRRX (1.76B). VSCIX pays higher dividends than SSRRX: VSCIX (1.23) vs SSRRX (0.00). SSRRX was incepted earlier than VSCIX: SSRRX (12 years) vs VSCIX (29 years). SSRRX (0.84) is less costly to investors than VSCIX (0.03). SSRRX is a more actively managed with annual turnover of: 47.00 vs. VSCIX (17.00). SSRRX has a lower initial minimum investment than VSCIX: SSRRX (50000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. SSRRX (19.19). VSCIX return over 5 years is better than : 35.13 vs. SSRRX (10.95).
SSRRXVSCIXSSRRX / VSCIX
Total Expense Ratio0.800.032,667%
Annual Report Gross Expense Ratio0.840.032,800%
Fund Existence12 years29 years-
Gain YTD15.58214.591107%
Front LoadN/AN/A-
Min. Initial Investment5000050000001%
Min. Initial Investment IRAN/AN/A-
Net Assets1.76B189B1%
Annual Yield % from dividends0.001.23-
Returns for 1 year19.1922.5885%
Returns for 3 years36.8643.4485%
Returns for 5 years10.9535.1331%
Returns for 10 years61.20156.0739%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C